Cargando…
Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
In this study, the bleomycin model of pulmonary fibrosis was utilized to investigate putative anti-fibrotic activity of Ac-SDKP in vivo. Male CD-1 mice received intra-tracheal bleomycin (BLEO, 1 mg/kg) instillation in the absence or presence of Ac-SDKP (a dose of 0.6 mg/kg delivered intra-peritoneal...
Autores principales: | Conte, Enrico, Fagone, Evelina, Gili, Elisa, Fruciano, Mary, Iemmolo, Maria, Pistorio, Maria Provvidenza, Impellizzeri, Daniela, Cordaro, Marika, Cuzzocrea, Salvatore, Vancheri, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085123/ https://www.ncbi.nlm.nih.gov/pubmed/27029074 http://dx.doi.org/10.18632/oncotarget.8409 |
Ejemplares similares
-
Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms
por: Conte, Enrico, et al.
Publicado: (2011) -
Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
por: Zuo, Yiqin, et al.
Publicado: (2013) -
Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
por: Masuyer, Geoffrey, et al.
Publicado: (2015) -
The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis
por: Wang, Wei, et al.
Publicado: (2022) -
Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction
por: Nakagawa, Pablo, et al.
Publicado: (2018)